Results 261 to 270 of about 55,803 (311)

Spleen metastasis as rare systemic manifestation of thymoma: a case report. [PDF]

open access: yesMediastinum
Decaluwé T   +8 more
europepmc   +1 more source

Therapeutic intravenous immunoglobulins

Molecular Immunology, 2005
Intravenous immunoglobulins (IVIg) are concentrated formulations of human IgG prepared by industrial fractionation of large pools of individual plasma donations. IVIg were developed 20 years ago for the prophylaxis support of immunodeficient patients.
Réal, Lemieux   +2 more
openaire   +2 more sources

Intravenous immunoglobulin

Clinical Immunology and Immunopathology, 1986
The development of immunoglobulin preparations suitable for intravenous use that are safe, acceptable, and efficacious represents a major advance in the treatment of immunodeficient patients. Experience in the United States and elsewhere in the world indicates that the benefits of use in patients with well-documented humoral immunodeficiency far ...
openaire   +2 more sources

Safety of Intravenous Immunoglobulin

Archives of Neurology, 1993
The current position of intravenous immunoglobulin (IVIG) in neurology is similar to that of plasmapheresis 10 years ago. Therapeutic claims have been made for an increasing number of neurologic disorders, based on small, uncontrolled studies. With the recent publication of a controlled trial of IVIG treatment in Guillain-Barre syndrome, 1 and trials ...
C A, Thornton, M, Ballow
openaire   +2 more sources

Human intravenous immunoglobulin therapy

Seminars in Veterinary Medicine and Surgery: Small Animal, 1997
Human intravenous immunoglobulin (hIVIG) is a preparation of normal polyspecific IgG obtained from the plasma of healthy blood donors. Although purified immunoglobulins were initially developed for treatment of primary immunodeficiency syndromes, they have since been documented to be effective in the treatment of some immune-mediated diseases such as ...
J. Catharine   +2 more
openaire   +2 more sources

Intravenous Immunoglobulin and Atherosclerosis

Clinical Reviews in Allergy & Immunology, 2005
Several inflammatory and immunological factors have been established as important contributors to atherogenesis. Among these, oxidized low-density lipoprotein (oxLDL) play a central role in the initiation and progression of atherosclerotic lesions. In atherosclerotic lesions, oxLDL was also found to co-localize with beta2-glycoprotein I (beta2-GPI ...
Eiji, Matsuura   +3 more
openaire   +2 more sources

SAFETY OF INTRAVENOUS IMMUNOGLOBULIN

The Lancet, 1987
W L, Shaw, R R, Stewart
openaire   +2 more sources

Home - About - Disclaimer - Privacy